169 related articles for article (PubMed ID: 32143135)
1. A Glial-Neuronal Circuit in the Median Eminence Regulates Thyrotropin-Releasing Hormone-Release via the Endocannabinoid System.
Farkas E; Varga E; Kovács B; Szilvásy-Szabó A; Cote-Vélez A; Péterfi Z; Matziari M; Tóth M; Zelena D; Mezriczky Z; Kádár A; Kővári D; Watanabe M; Kano M; Mackie K; Rózsa B; Ruska Y; Tóth B; Máté Z; Erdélyi F; Szabó G; Gereben B; Lechan RM; Charli JL; Joseph-Bravo P; Fekete C
iScience; 2020 Mar; 23(3):100921. PubMed ID: 32143135
[TBL] [Abstract][Full Text] [Related]
2. Tanycyte specific ablation of diacylglycerol lipase alpha stimulates the hypothalamic-pituitary-thyroid axis by decreasing the endocannabinoid mediated inhibition of TRH release.
Kővári D; Penksza V; Szilvásy-Szabó A; Sinkó R; Gereben B; Mackie K; Fekete C
J Neuroendocrinol; 2022 Jan; 34(1):e13079. PubMed ID: 34970803
[TBL] [Abstract][Full Text] [Related]
3. Tanycytes and the Control of Thyrotropin-Releasing Hormone Flux Into Portal Capillaries.
Rodríguez-Rodríguez A; Lazcano I; Sánchez-Jaramillo E; Uribe RM; Jaimes-Hoy L; Joseph-Bravo P; Charli JL
Front Endocrinol (Lausanne); 2019; 10():401. PubMed ID: 31293518
[TBL] [Abstract][Full Text] [Related]
4. Tanycytes control the hormonal output of the hypothalamic-pituitary-thyroid axis.
Müller-Fielitz H; Stahr M; Bernau M; Richter M; Abele S; Krajka V; Benzin A; Wenzel J; Kalies K; Mittag J; Heuer H; Offermanns S; Schwaninger M
Nat Commun; 2017 Sep; 8(1):484. PubMed ID: 28883467
[TBL] [Abstract][Full Text] [Related]
5. Tanycyte pyroglutamyl peptidase II contributes to regulation of the hypothalamic-pituitary-thyroid axis through glial-axonal associations in the median eminence.
Sánchez E; Vargas MA; Singru PS; Pascual I; Romero F; Fekete C; Charli JL; Lechan RM
Endocrinology; 2009 May; 150(5):2283-91. PubMed ID: 19179432
[TBL] [Abstract][Full Text] [Related]
6. GLP-1 Receptor Signaling Has Different Effects on the Perikarya and Axons of the Hypophysiotropic Thyrotropin-Releasing Hormone Synthesizing Neurons in Male Mice.
Ruska Y; Peterfi Z; Szilvásy-Szabó A; Kővári D; Hrabovszky E; Dorogházi B; Gereben B; Tóth B; Matziari M; Wittmann G; Fekete C
Thyroid; 2024 Feb; 34(2):252-260. PubMed ID: 38062754
[No Abstract] [Full Text] [Related]
7. Type 1 cannabinoid receptor-containing axons innervate hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons.
Deli L; Wittmann G; Kalló I; Lechan RM; Watanabe M; Liposits Z; Fekete C
Endocrinology; 2009 Jan; 150(1):98-103. PubMed ID: 18818298
[TBL] [Abstract][Full Text] [Related]
8. Colchicine treatment differently affects releasable thyrotropin-releasing hormone (TRH) pools in the hypothalamic paraventricular nucleus (PVN) and the median eminence (ME).
Alexander K; Nikodémová M; Kucerová J; Strbák V
Cell Mol Neurobiol; 2005 Jun; 25(3-4):681-95. PubMed ID: 16075386
[TBL] [Abstract][Full Text] [Related]
9. Fasting Enhances Pyroglutamyl Peptidase II Activity in Tanycytes of the Mediobasal Hypothalamus of Male Adult Rats.
Lazcano I; Cabral A; Uribe RM; Jaimes-Hoy L; Perello M; Joseph-Bravo P; Sánchez-Jaramillo E; Charli JL
Endocrinology; 2015 Jul; 156(7):2713-23. PubMed ID: 25942072
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine implications for the association between cocaine- and amphetamine regulated transcript (CART) and hypophysiotropic thyrotropin-releasing hormone (TRH).
Fekete C; Lechan RM
Peptides; 2006 Aug; 27(8):2012-8. PubMed ID: 16730860
[TBL] [Abstract][Full Text] [Related]
11. Advances in TRH signaling.
Joseph-Bravo P; Jaimes-Hoy L; Charli JL
Rev Endocr Metab Disord; 2016 Dec; 17(4):545-558. PubMed ID: 27515033
[TBL] [Abstract][Full Text] [Related]
12. Feedback regulation of thyrotropin-releasing hormone (TRH): mechanisms for the non-thyroidal illness syndrome.
Lechan RM; Fekete C
J Endocrinol Invest; 2004; 27(6 Suppl):105-19. PubMed ID: 15481810
[TBL] [Abstract][Full Text] [Related]
13. Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions.
Fekete C; Lechan RM
Endocr Rev; 2014 Apr; 35(2):159-94. PubMed ID: 24423980
[TBL] [Abstract][Full Text] [Related]
14. Different regulation of thyrotropin releasing hormone content and release in paraventricular nucleus (PVN) and median eminence (ME) of rat hypothalamus during in vitro incubation.
Nikodémová M; Strbák V
Life Sci; 1995; 56(18):1511-21. PubMed ID: 7752815
[TBL] [Abstract][Full Text] [Related]
15. 60 YEARS OF NEUROENDOCRINOLOGY: TRH, the first hypophysiotropic releasing hormone isolated: control of the pituitary-thyroid axis.
Joseph-Bravo P; Jaimes-Hoy L; Uribe RM; Charli JL
J Endocrinol; 2015 Aug; 226(2):T85-T100. PubMed ID: 26101376
[TBL] [Abstract][Full Text] [Related]
16. Association of cocaine- and amphetamine-regulated transcript-immunoreactive elements with thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and its role in the regulation of the hypothalamic-pituitary-thyroid axis during fasting.
Fekete C; Mihály E; Luo LG; Kelly J; Clausen JT; Mao Q; Rand WM; Moss LG; Kuhar M; Emerson CH; Jackson IM; Lechan RM
J Neurosci; 2000 Dec; 20(24):9224-34. PubMed ID: 11125000
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin-releasing hormone (TRH) in the brain and pituitary of the teleost, Clarias batrachus and its role in regulation of hypophysiotropic dopamine neurons.
Singh O; Pradhan DR; Nagalakashmi B; Kumar S; Mitra S; Sagarkar S; Sakharkar AJ; Lechan RM; Singru PS
J Comp Neurol; 2019 Apr; 527(6):1070-1101. PubMed ID: 30370602
[TBL] [Abstract][Full Text] [Related]
18. Mapping of thyrotropin-releasing hormone (TRH) neuronal systems of rat forebrain projecting to the median eminence and the OVLT. Immunocytochemistry combined with retrograde labeling at the light and electron microscopic levels.
Merchenthaler I; Liposits Z
Acta Biol Hung; 1994; 45(2-4):361-74. PubMed ID: 7725828
[TBL] [Abstract][Full Text] [Related]
19. NEW INSIGHTS INTO THE HYPOTHALAMIC-PITUITARY-THYROID AXIS.
Duntas LH
Acta Endocrinol (Buchar); 2016; 12(2):125-129. PubMed ID: 31149076
[TBL] [Abstract][Full Text] [Related]
20. The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?
Charli JL; Rodríguez-Rodríguez A; Hernández-Ortega K; Cote-Vélez A; Uribe RM; Jaimes-Hoy L; Joseph-Bravo P
Front Pharmacol; 2020; 11():640. PubMed ID: 32457627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
